Its coming, and it should move the share price back to IPO levels of 25-26 cents.
Details:
1. ASX announcement 2 weeks ago.
"Regeneus is in discussions with Japanese Partners" ... "If discussions are successful they could be expected to have a positive effect on the price"
2. Todays Presentation "Progressed licensing discussions for manufacturing clinical development and commercialisation in Japan"
3. Todays Presentation (page 22).. " Secure Manufacturing and commercial partner for Progenza technology in Japan".... "Q1 FY17" Q1 FY17 = July,Aug,September.
So they are basically stating they are still on target for a Japanese partner by September.
Watch this space.
RGS Price at posting:
15.5¢ Sentiment: Buy Disclosure: Held
